Body composition as a predictor of chemotherapy toxicity in patients with metastatic prostate cancer treated with docetaxel. (22nd April 2015) - Cushen, S. J.; Power, D. G.; McDermot, R.; O'Sullivan, K.; Maceneaney, P.; Daly, L.; Ryan, A. M.